Allergan completes transfer of European MA for Ironwood’s CONSTELLA® from Almirall S.A

CONSTELLA® is the only available prescription treatment with a European Marketing Authorisation specifically for irritable bowel syndrome with constipation

Source: Pharmacy Europe - March 3, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Legislation & regulation Gastroenterology Patient care constella constipation IBS-C irritable bowel syndrome Latest News marketing authorisation Source Type: news